These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 1477928

  • 1. Enhancing effect of cyclodextrins on nasal absorption of insulin and its duration in rabbits.
    Watanabe Y, Matsumoto Y, Kawamoto K, Yazawa S, Matsumoto M.
    Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3100-4. PubMed ID: 1477928
    [Abstract] [Full Text] [Related]

  • 2. Absorption enhancement of polypeptide drugs by cyclodextrins. I. Enhanced rectal absorption of insulin from hollow-type suppositories containing insulin and cyclodextrins in rabbits.
    Watanabe Y, Matsumoto Y, Seki M, Takase M, Matsumoto M.
    Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3042-7. PubMed ID: 1477920
    [Abstract] [Full Text] [Related]

  • 3. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.
    Arima H, Yunomae K, Miyake K, Irie T, Hirayama F, Uekama K.
    J Pharm Sci; 2001 Jun; 90(6):690-701. PubMed ID: 11357172
    [Abstract] [Full Text] [Related]

  • 4. Mutual inhibition of the insulin absorption-enhancing properties of dodecylmaltoside and dimethyl-beta-cyclodextrin following nasal administration.
    Ahsan F, Arnold JJ, Meezan E, Pillion DJ.
    Pharm Res; 2001 May; 18(5):608-14. PubMed ID: 11465415
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Release characteristics of endogenous constituents by exposure of small intestine to modified beta-cyclodextrins.
    Tanino T, Ogiso T, Iwaki M, Yamaguchi T, Kakehi K.
    Biol Pharm Bull; 1999 Oct; 22(10):1099-105. PubMed ID: 10549863
    [Abstract] [Full Text] [Related]

  • 12. Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells.
    Motoyama K, Kameyama K, Onodera R, Araki N, Hirayama F, Uekama K, Arima H.
    Eur J Pharm Sci; 2009 Oct 08; 38(3):249-61. PubMed ID: 19664706
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activity.
    Hirayama F, Mieda S, Miyamoto Y, Arima H, Uekama K.
    J Pharm Sci; 1999 Oct 08; 88(10):970-5. PubMed ID: 10514341
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
    Arima H, Yunomae K, Hirayama F, Uekama K.
    J Pharmacol Exp Ther; 2001 May 08; 297(2):547-55. PubMed ID: 11303042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.